🇺🇸 FDA
Patent

US 8999352

Genetically engineered swine influenza virus and uses thereof

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 8999352 (Genetically engineered swine influenza virus and uses thereof) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/544, A61K2039/552